Preclinical studies of a PARP targeted, Meitner-Auger emitting, theranostic radiopharmaceutical for metastatic ovarian cancer.
Hoffman SLV, Mixdorf JC, Kwon O, Johnson TR, Makvandi M, Lee H, Aluicio-Sarduy E, Barnhart TE, Jeffery JJ, Patankar MS, Engle JW, Bednarz BP, Ellison PA.
Hoffman SLV, et al. Among authors: patankar ms.
Nucl Med Biol. 2023 Jul-Aug;122-123:108368. doi: 10.1016/j.nucmedbio.2023.108368. Epub 2023 Jul 19.
Nucl Med Biol. 2023.
PMID: 37490805
Free PMC article.